SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Genaera Corp

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jstrohs who wrote (80)5/18/2006 12:13:44 AM
From: DewDiligence_on_SI  Read Replies (1) of 96
 
Who the heck is Dawson James? Are they one of those firms that publishes “research” for hire?

GENR’s Evizon program is dead in the water because patients are not enrolling in the phase-3 trial. This is hardly surprising—why would anyone with half a brain enroll in a placebo-controlled trial when there are better options available and Lucentis will in all likelihood be on the market in a couple of months?

GENR is in serious trouble. The DJ report strikes me as a whitewash.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext